Albany, NY -- (SBWIRE) -- 06/02/2015 -- Pneumonia is a lung infection caused by bacteria or viruses. Infection of pneumonia occurred due to social contact is referred as community acquired pneumonia (CAP). Pathogens that cause community acquired pneumonia (CAP) are Haemophilus influenza, Streptococcus pneumonia, atypical bacteria namely Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella sp.

Browse Full Report with TOC http://www.transparencymarketresearch.com/community-acquired-pneumonia-market.html

Common symptoms of community acquired pneumonia include, cough, fever, chest pain, tachycardia, sudden loss of appetite, hypothermia, excessive fatigue, nausea, vomiting, migraine, blueness of skin, coughing up blood and rapid and painful breathing. Every year 4 million to 5 million new cases of community acquired pneumonia (CAP) are detected globally, out of which 25% of the cases require hospitalization. Based on the diagnosis type, the global community acquired pneumonia market is classified as follows:

Chest radiography

Laboratory Testing

- Blood Cultures
- Sputum Testing
- Urine Testing
- Pneumococcal Antigen Testing
- Creatine Phosphokinase (CPK) Levels
- Ferritin Levels
- C-reactive Protein (CRP) Levels
- Procalcitonin Levels
- Others

Based on the treatment, the global community acquired pneumonia market is segmented as follows:

Antibiotic Therapy

- Amoxicillin
- Amoxicillin/Clavulanate
- Ampicillin
- Ceftriaxone
- Azithromycin
- Pencillin G
- Cefotaxime
- Ciprofloxacin
- Levofloxacin
- Others

Antiviral therapy

- Ribavirin
- Oseltamivir
- Acyclovir
- Others

Rising incidences of the disease worldwide coupled with increasing awareness about availability of disease related treatments are the major factors that are driving the global community acquired pneumonia market towards growth. While on the other hand, rising drug resistance among disease causing pathogens is one of the major factors restraining the growth of the global community acquired pneumonia (CAP) market.

Geographically, the global community acquired pneumonia (CAP) market is segmented into North America, Europe, Asia Pacific and Rest of the World (RoW). North America comprises community acquired pneumonia (CAP) market for the U.S and Canada. Europe comprises cumulative market of community acquired pneumonia (CAP) in Germany, Italy, France, Spain, and Rest of Europe (RoE). Asia Pacific comprises cumulative market of community acquired pneumonia (CAP) in China, India, Australia, New Zealand and rest of Asia Pacific (RoAPAC). Rest of the World (RoW) comprises community acquired pneumonia (CAP) market in Latin America, Middle East and Russia. Europe and North America are dominating the global community acquired pneumonia (CAP) market. Highly developed healthcare infrastructure, high awareness about availability of diagnostic tests and treatment therapies coupled with presence of well structured regulatory framework are some of the factors that are driving the Europe and North American community acquired pneumonia market. Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period from 2014 to 2020. Rapidly improving healthcare infrastructure on the grounds of booming medical tourism industry in this region is the prime driver for growth of the community acquired pneumonia (CAP) market in Asia Pacific. In addition, swiftly rising disposable income, coupled with availability of government funds to improve healthcare facilities in the region are some other factors that are fueling the growth of the community acquired pneumonia (CAP) market in Asia Pacific region. India, Japan, China, and South Korea are the fastest growing markets in Asia Pacific region. Moreover, Argentina, Mexico and Brazil are the countries in Rest of the World (RoW) region that are expected to show faster growth in this region.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

- North America
- Asia Pacific
- Europe
- Rest of the World

This report provides comprehensive analysis of

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter's five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Report on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR's experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4314

Latest Press Release Reports: http://www.transparencymarketresearch.com/press-releases.htm

Latest Articles Reports: http://www.transparencymarketresearch.com/articles.htm

Contact Us:
Mr. Nachiket Ghumare
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tel: 518-618-1030
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Market Research Blog: https://pharmaceuticalmarket.wordpress.com/